AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Stock market
U.S. Treasury, Commerce secretaries and Trade Representative to meet Chinese reps
June 07, 2025 05:25 AM AEST| By InvestingInvesting.com -- A meeting has been scheduled in London for Monday, June 9, 2025, between top U.S. officials and representatives from China. This was announced by President Trump on the social media p
Neo Performance Materials stock surges on buyback plan
June 07, 2025 04:09 AM AEST| By InvestingInvesting.com -- Shares of Neo Performance Materials Inc (TSX:NEO) climbed 7.1% following the announcement of a Normal Course Issuer Bid (NCIB) and the commencement of trading on the OTCQX market. The
BofA sees termination of Owens–Rotech deal as surprising but potentially positive
June 07, 2025 04:07 AM AEST| By InvestingInvesting.com -- Bank of America said Owens&Minor’s decision to terminate its planned acquisition of Rotech Healthcare was unexpected but may ultimately prove beneficial, allowing the company to ref
Goldman Sachs initiates coverage on generic drugmakers, sees upside in Teva and Am
June 07, 2025 03:57 AM AEST| By InvestingInvesting.com -- Goldman Sachs initiated coverage on U.S.-listed generic pharmaceutical companies with Buy ratings on Teva Pharmaceutical Industries (NYSE:TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX
Morgan Stanley upgrades Applied Materials on derisked outlook for China
June 07, 2025 03:21 AM AEST| By InvestingInvesting.com -- Morgan Stanley upgraded Applied Materials (NASDAQ:AMAT) to Equal-Weight from Underweight, citing a partially derisked outlook for China and its ICAPS business, but warned that weaknes
Phathom Pharmaceuticals shares soar on FDA exclusivity grant
June 07, 2025 03:03 AM AEST| By InvestingInvesting.com -- Shares of Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) soared 128% after the FDA granted the company’s petition for exclusivity in the Orange Book listing for its drug Voquezna (vono
Jefferies upgrades Urban Outfitters to Hold, says risk/reward now balanced
June 07, 2025 02:31 AM AEST| By InvestingInvesting.com -- Jefferies upgraded Urban Outfitters (NASDAQ:URBN) to Hold from Underperform, citing strong performance across most of its brands and a clearer path to margin recovery, though adding t
Melius upgrades Deere on long-term tech moat and recurring revenue upside
June 07, 2025 01:55 AM AEST| By InvestingInvesting.com -- Melius Research upgraded Deere (NYSE:DE) to Buy and raised its two-year price target to $750, saying the equipment maker’s leadership in agricultural technology is poised to deliver
UAE’s data center project with U.S. tech firms faces security concerns
June 07, 2025 01:43 AM AEST| By InvestingInvesting.com -- A massive deal to create one of the world’s largest data center hubs in the United Arab Emirates (UAE) with American technology, continues to face persistent security concerns, acco
Taseko Mines shares surge on landmark agreement with Tŝilhqot’in Nation
June 07, 2025 01:23 AM AEST| By InvestingInvesting.com -- Taseko Mines (NYSE:TGB) Ltd (TSX:TKO) stock soared over 15% Friday following the announcement of a significant agreement with the Tŝilhqot’in Nation and the Province of British Col
Will Amazon’s robot delivery ambitions pay off?
June 07, 2025 01:21 AM AEST| By InvestingInvesting.com -- Bank of America analysts suggest that Amazon (NASDAQ:AMZN)’s burgeoning ambitions in robot delivery could yield "billions in savings," despite acknowledging significant hurdles.
Citi upgrades Invitation Homes, downgrades American Homes 4 Rent on valuation gap
June 07, 2025 01:17 AM AEST| By InvestingInvesting.com --Citi upgraded Invitation Homes (NYSE:INVH) to Buy and downgraded American Homes (NYSE:AMH) 4 Rent to Neutral, citing relative valuation and expectations that Invitation Homes’ earnin
Trump urges Federal Reserve for a full point rate cut
June 07, 2025 01:01 AM AEST| By InvestingInvesting.com -- President Donald Trump has intensified his pressure on the Federal Reserve, urging for a full percentage point cut in rates. On Friday, Trump took to social media to criticize Chair J
Bernstein downgrades CrowdStrike on valuation, sees better upside in Palo Alto
June 07, 2025 12:37 AM AEST| By InvestingInvesting.com -- Bernstein downgraded CrowdStrike (NASDAQ:CRWD) to Market-Perform from Outperform, as its stretched valuation offset cybersecurity firm’s strong fundamentals and continued revenue an
Berenberg downgrades OCI, says divestment cycle nearing end
June 07, 2025 12:03 AM AEST| By InvestingInvesting.com -- Berenberg downgraded OCI to Hold from Buy, saying the company’s years-long strategic reshaping is close to completion and leaves limited upside for shareholders.
Goldman Sachs lowers MYR Group, raises MasTec
June 06, 2025 11:45 PM AEST| By InvestingInvesting.com -- Goldman Sachs has adjusted its ratings for two players in the U.S. energy services sector, upgrading MasTec (NYSE:MTZ) to Buy while downgrading MYR Group (NASDAQ:MYRG) to Neutral.
ADI, TXN named top semiconductor picks by Citi
June 06, 2025 11:21 PM AEST| By InvestingInvesting.com -- Citi analysts have maintained their 2025 semiconductor sales forecast of an 8% year-over-year increase, despite April sales falling below seasonal expectations.
Virgin Galactic stock jumps on SpaceX competition speculation
June 06, 2025 10:25 PM AEST| By InvestingInvesting.com -- Shares of Virgin Galactic (NYSE:SPCE) surged 10% in premarket trading, while Rocket Lab (NASDAQ:RKLB) rose 3.5%, and Boeing (NYSE:BA) saw a modest 0.5% uptick. The movement comes afte
EMA says Ozempic, Wegovy may cause rare eye condition
June 06, 2025 10:13 PM AEST| By InvestingInvesting.com -- The European Medicines Agency’s (EMA) safety committee, PRAC, said Friday that it has concluded that Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a rare eye condition t
Vera Therapeutics stock sinks following competitor’s successful trial
June 06, 2025 10:07 PM AEST| By InvestingInvesting.com -- Shares of Vera Therapeutics (NASDAQ:VERA) tumbled by 33% in premarket trading today after a Japanese competitor, Otsuka, reported positive results from a Phase 3 trial of a competing
Advertise your brand on Kalkine Media